Pharma

Novartis launches new share buyback for up to 10% of its stock

March 13, 2023 05:19 PM AEDT | By Reuters

ZURICH (Reuters) - Novartis has launched a new share buyback programme to purchase up to 10% of the pharma company's own shares over the next three ye...

Indonesia court hears class-action suit after children die from tain...

January 17, 2023 07:33 PM AEDT | By Reuters

JAKARTA (Reuters) - Families of Indonesian children who died because of tainted cough syrup demanded restitution as an Indonesian court on Tuesday sta...

U.S. FDA, CDC see early signal of possible Pfizer bivalent COVID sho...

January 15, 2023 05:53 AM AEDT | By Reuters

(This Jan. 13 story has been refiled with edited headline to clarify that the link to a stroke is possible, not definite) (Reuters) - A safety monitor...

EMA seeks to issue guidance on liver damage from Novartis' gene ther...

January 14, 2023 01:24 AM AEDT | By Reuters

(Reuters) - The European Medicines Agency (EMA) said on Friday it is looking into issuing advice for physicians using Novartis AG's Zolgensma, calling...

U.S. to announce list of drugs for pricing negotiations Sept. 1

January 12, 2023 03:11 AM AEDT | By Reuters

By Ahmed Aboulenein WASHINGTON (Reuters) - The U.S. government will announce a list of 10 prescription drugs for which it plans to negotiate the price...

U.S. extends COVID-19 public health emergency status - CNBC

January 12, 2023 02:42 AM AEDT | By Reuters

(Reuters) -The United States on Wednesday extended the COVID-19 pandemic's status as a public health emergency until April, CNBC reported on Wednesday...

Bayer flags new blood thinner as $5 billion-plus opportunity

January 11, 2023 12:06 AM AEDT | By Reuters

By Ludwig Burger and Patricia Weiss FRANKFURT (Reuters) - Bayer predicted on Tuesday its experimental drug against dangerous blood clots could make mo...

U.S. FDA grants priority review to Roche's bispecific antibody Glofi...

January 06, 2023 05:34 PM AEDT | By Reuters

ZURICH (Reuters) - Roche announced on Friday the U.S. Food and Drug Administration has granted priority review to the Swiss pharmaceutical company's b...

Walgreens to pause M&A deals, focus on healthcare pivot

January 06, 2023 05:30 AM AEDT | By Reuters

By Raghav Mahobe and Aditya Samal (Reuters) - Walgreens Boots Alliance said on Thursday it will not strike new deals in the short term after a spate o...

Japan drugmaker Eisai's shares slump after report of 3rd death in Al...

December 23, 2022 04:31 PM AEDT | By Reuters

TOKYO (Reuters) - Eisai Co slid as much as 6.5% in Tokyo trading on Friday after a report of a third death in a trial of an Alzheimer's disease treatm...

Indonesia to produce Merck's HPV vaccines to combat cervical cancer

December 13, 2022 07:55 PM AEDT | By Reuters

JAKARTA (Reuters) - Indonesia will produce drugmaker Merck & Co's vaccines for human papillomavirus (HPV), the chief of its state-owned pharmaceut...

Japan's Meiji Holdings says drug unit started late-stage trial for C...

December 13, 2022 05:47 PM AEDT | By Reuters

TOKYO (Reuters) - Japan's Meiji Holdings Co said on Tuesday its drug subsidiary had started a Phase III trial of an mRNA-based vaccine for COVID-19. M...

Malaria deaths dip in 2021 after rising in first year of COVID, says...

December 08, 2022 10:17 PM AEDT | By Reuters

By Pratik Jain (Reuters) - Malaria-related deaths fell slightly in 2021 after a significant increase in the first year of COVID-19, but remained highe...

Eisai, Biogen Alzheimer's drug could be available to some next year

December 01, 2022 07:19 AM AEDT | By Reuters

By Deena Beasley and Julie Steenhuysen SAN FRANCISCO (Reuters) - Japan's Eisai Co plans to seek full approval of its experimental Alzheimer's drug lec...

Eisai, Biogen Alzheimer's drug slows cognitive decline, safety for s...

November 30, 2022 12:21 PM AEDT | By Reuters

By Deena Beasley SAN FRANCISCO (Reuters) -An experimental Alzheimer's drug from Eisai and Biogen slowed cognitive decline in a closely watched trial b...

Japanese drugmaker Eisai's shares drop on report of death in Alzheim...

November 30, 2022 11:53 AM AEDT | By Reuters

TOKYO (Reuters) - Shares in Japanese drugmaker Eisai Co fell more than 6% on Tuesday after a report that a woman who was enrolled in a trial of the co...

Analysis-U.S. midterms dampen Big Pharma hopes for drug price policy...

November 19, 2022 06:18 AM AEDT | By Reuters

By Ahmed Aboulenein WASHINGTON (Reuters) - The divided U.S. Congress after the November midterm elections undermines pharmaceutical companies who want...

Cancer diagnoses lag after screenings fall during pandemic, U.S. stu...

November 18, 2022 03:28 AM AEDT | By Reuters

By Shawana Alleyne-Morris (Reuters) - Screenings for a variety of common cancers have not returned to pre-pandemic levels, potentially leading to diag...

Fake account shows 'challenges' with Twitter - Lilly CEO

November 17, 2022 06:42 AM AEDT | By Reuters

(Reuters) - Eli Lilly & Co Chief Executive Officer Dave Ricks said on Wednesday that the recent imposter Twitter account incident "demonstrates so...

AstraZeneca tops quarterly estimates buoyed by cancer drugs

November 10, 2022 09:46 PM AEDT | By Reuters

By Natalie Grover (Reuters) - AstraZeneca on Thursday raised its full-year adjusted earnings forecast after third-quarter profit and revenue topped an...

Markets

Pharma

Recent Articles

Top ASX Listed Companies